AMERISAFE (NASDAQ:AMSF – Get Free Report) will likely be issuing its Q3 2025 results after the market closes on Wednesday, October 29th. Analysts expect the company to announce earnings of $0.55 per share and revenue of $78.2860 million for the quarter. Investors can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Thursday, October 30, 2025 at 10:30 AM ET.
AMERISAFE Stock Down 0.6%
AMSF opened at $41.19 on Tuesday. AMERISAFE has a 52-week low of $40.03 and a 52-week high of $60.24. The firm has a market capitalization of $782.24 million, a P/E ratio of 15.60 and a beta of 0.32. The firm’s 50 day moving average is $43.82 and its 200-day moving average is $45.19.
Insiders Place Their Bets
In other news, CFO Anastasios Omiridis sold 1,343 shares of the business’s stock in a transaction that occurred on Tuesday, August 5th. The stock was sold at an average price of $44.75, for a total value of $60,099.25. Following the completion of the sale, the chief financial officer directly owned 2,253 shares in the company, valued at approximately $100,821.75. The trade was a 37.35% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.61% of the stock is currently owned by corporate insiders.
Institutional Trading of AMERISAFE
Wall Street Analyst Weigh In
Several research firms recently issued reports on AMSF. Truist Financial dropped their price target on shares of AMERISAFE from $54.00 to $50.00 and set a “hold” rating on the stock in a research note on Monday, July 28th. JMP Securities dropped their target price on AMERISAFE from $65.00 to $60.00 and set a “market outperform” rating on the stock in a research report on Tuesday, October 14th. Wall Street Zen upgraded AMERISAFE from a “sell” rating to a “hold” rating in a report on Sunday, August 17th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of AMERISAFE in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $55.00.
Read Our Latest Research Report on AMERISAFE
About AMERISAFE
AMERISAFE, Inc, an insurance holding company, underwrites workers’ compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Featured Articles
- Five stocks we like better than AMERISAFE
- Best Stocks Under $5.00
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- Conference Calls and Individual Investors
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- What Are Growth Stocks and Investing in Them
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.
